215 related articles for article (PubMed ID: 31144621)
1. Development of a Single-Site Device for Conjoined Glucose Sensing and Insulin Delivery in Type-1 Diabetes Patients.
Tschaikner M; Simic A; Jungklaus M; Fritz M; Ellmerer M; Pieber TR; Regittnig W
IEEE Trans Biomed Eng; 2020 Jan; 67(1):312-322. PubMed ID: 31144621
[TBL] [Abstract][Full Text] [Related]
2. Novel Single-Site Device for Conjoined Glucose Sensing and Insulin Infusion: Performance Evaluation in Diabetes Patients During Home-Use.
Tschaikner M; Powell K; Jungklaus M; Fritz M; Ellmerer M; Hovorka R; Lane S; Pieber TR; Regittnig W
IEEE Trans Biomed Eng; 2020 Jan; 67(1):323-332. PubMed ID: 31251175
[TBL] [Abstract][Full Text] [Related]
3. Performance and acceptability of a combined device for insulin infusion and glucose sensing in the home setting.
Nørgaard K; Shin J; Welsh JB; Gjessing H
J Diabetes Sci Technol; 2015 Mar; 9(2):215-20. PubMed ID: 25591857
[TBL] [Abstract][Full Text] [Related]
4. First application of a transcutaneous optical single-port glucose monitoring device in patients with type 1 diabetes mellitus.
Rumpler M; Mader JK; Fischer JP; Thar R; Granger JM; Deliane F; Klimant I; Aberer F; Sinner F; Pieber TR; Hajnsek M
Biosens Bioelectron; 2017 Feb; 88():240-248. PubMed ID: 27554063
[TBL] [Abstract][Full Text] [Related]
5. Feasibility of adjacent insulin infusion and continuous glucose monitoring via the Medtronic Combo-Set.
O'Neal DN; Adhya S; Jenkins A; Ward G; Welsh JB; Voskanyan G
J Diabetes Sci Technol; 2013 Mar; 7(2):381-8. PubMed ID: 23566996
[TBL] [Abstract][Full Text] [Related]
6. An Amperometric Glucose Sensor Integrated into an Insulin Delivery Cannula: In Vitro and In Vivo Evaluation.
Ward WK; Heinrich G; Breen M; Benware S; Vollum N; Morris K; Knutsen C; Kowalski JD; Campbell S; Biehler J; Vreeke MS; Vanderwerf SM; Castle JR; Cargill RS
Diabetes Technol Ther; 2017 Apr; 19(4):226-236. PubMed ID: 28221814
[TBL] [Abstract][Full Text] [Related]
7. [From insulin pump and continuous glucose monitoring to the artificial pancreas].
Apablaza P; Soto N; Codner E
Rev Med Chil; 2017 May; 145(5):630-640. PubMed ID: 28898340
[TBL] [Abstract][Full Text] [Related]
8. Emerging Technologies for Diabetes Care.
Bailey TS; Walsh J; Stone JY
Diabetes Technol Ther; 2018 Jun; 20(S2):S278-S284. PubMed ID: 29916738
[TBL] [Abstract][Full Text] [Related]
9. The International Diabetes Closed-Loop Study: Testing Artificial Pancreas Component Interoperability.
Anderson SM; Dassau E; Raghinaru D; Lum J; Brown SA; Pinsker JE; Church MM; Levy C; Lam D; Kudva YC; Buckingham B; Forlenza GP; Wadwa RP; Laffel L; Doyle FJ; DeVries JH; Renard E; Cobelli C; Boscari F; Del Favero S; Kovatchev BP
Diabetes Technol Ther; 2019 Feb; 21(2):73-80. PubMed ID: 30649925
[TBL] [Abstract][Full Text] [Related]
10. Numerical and clinical precision of continuous glucose monitoring in Colombian patients treated with insulin infusion pump with automated suspension in hypoglycemia.
Gómez AM; Marín Sánchez A; Muñoz OM; Colón Peña CA
Endocrinol Nutr; 2015 Dec; 62(10):485-92. PubMed ID: 26531841
[TBL] [Abstract][Full Text] [Related]
11. Emerging Technologies for the Management of Type 1 Diabetes in Pregnancy.
Yamamoto JM; Murphy HR
Curr Diab Rep; 2018 Jan; 18(1):4. PubMed ID: 29383544
[TBL] [Abstract][Full Text] [Related]
12. Measuring glucose at the site of insulin delivery with a redox-mediated sensor.
Jacobs PG; Tyler NS; Vanderwerf SM; Mosquera-Lopez C; Seidl T; Cargill R; Branigan D; Ramsey K; Morris K; Benware S; Ward WK; Castle JR
Biosens Bioelectron; 2020 Oct; 165():112221. PubMed ID: 32729464
[TBL] [Abstract][Full Text] [Related]
13. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
[TBL] [Abstract][Full Text] [Related]
14. Insulin Infusion Sets and Continuous Glucose Monitoring Sensors: Where the Artificial Pancreas Meets the Patient.
Forlenza GP
Diabetes Technol Ther; 2017 Apr; 19(4):206-208. PubMed ID: 28418732
[No Abstract] [Full Text] [Related]
15. Perioperative Considerations for Evolving Artificial Pancreas Devices.
Long MT; Coursin DB; Rice MJ
Anesth Analg; 2019 May; 128(5):902-906. PubMed ID: 30198923
[TBL] [Abstract][Full Text] [Related]
16. The Hybrid Closed-Loop System: Evolution and Practical Applications.
Weaver KW; Hirsch IB
Diabetes Technol Ther; 2018 Jun; 20(S2):S216-S223. PubMed ID: 29873517
[TBL] [Abstract][Full Text] [Related]
17. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.
Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E;
Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304
[TBL] [Abstract][Full Text] [Related]
18. Type-1 Diabetes Patient Decision Simulator for In Silico Testing Safety and Effectiveness of Insulin Treatments.
Vettoretti M; Facchinetti A; Sparacino G; Cobelli C
IEEE Trans Biomed Eng; 2018 Jun; 65(6):1281-1290. PubMed ID: 28866479
[TBL] [Abstract][Full Text] [Related]
19. Combining glucose monitoring and insulin delivery into a single device: current progress and ongoing challenges of the artificial pancreas.
Ang KH; Tamborlane WV; Weinzimer SA
Expert Opin Drug Deliv; 2015; 12(10):1579-82. PubMed ID: 26389567
[TBL] [Abstract][Full Text] [Related]
20. New Design of a Percutaneous Port System for Continuous Intraperitoneal Insulin Infusion.
Rieger C; Kurz K; Mueller-Hoffmann W; Gehr B; Liebl A
J Diabetes Sci Technol; 2019 Nov; 13(6):1158-1160. PubMed ID: 31195815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
